![](/img/cover-not-exists.png)
Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug Combinations
Lindholm, E. M., Krohn, M., Iadevaia, S., Kristian, A., Mills, G. B., Maelandsmo, G. M., Engebraaten, O.Volume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-13-1865
Date:
January, 2014
File:
PDF, 849 KB
english, 2014